Technical Analysis for QURE - uniQure N.V.

Grade Last Price % Change Price Change
F 36.7 -0.81% -0.30
QURE closed down 0.81 percent on Friday, February 26, 2021, on 80 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical QURE trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
20 DMA Support Bullish -0.81%
BB Squeeze Ended Range Expansion -0.81%
Crossed Above 20 DMA Bullish -2.05%
Bollinger Band Squeeze Range Contraction -2.05%
NR7 Range Contraction -2.05%
BB Squeeze Started Range Contraction -2.05%
20 DMA Resistance Bearish 1.10%
Older End-of-Day Signals for QURE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


uniQure N.V. Description

uniQure BV, a biopharmaceutical company, develops gene therapies through its modular technology platform for the treatment of genetic or acquired diseases. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency, an orphan metabolic disease. It also develops a pipeline of additional adeno-associated virus (AAV) based gene therapies, including AMT-060, a gene therapy for the treatment of hemophilia B; AMT-021 for acute intermittent porphyria; AMT-110 for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease, as well as various programs that are in early preclinical development stage. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, and University of California San Francisco. uniQure BV was founded in 1998 and is headquartered in Amsterdam, the Netherlands.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Diseases Clinical Development Genetics Gene Therapy Parkinson's Disease Metabolic Disease Applied Genetics Hemophilia Gene Delivery Lipoprotein Adeno Associated Virus Treatment Of Hemophilia Lipase Acute Intermittent Porphyria Alipogene Tiparvovec Glybera Hemophilia B Lipoprotein Lipase Deficiency

Is QURE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 71.45
52 Week Low 33.5901
Average Volume 558,239
200-Day Moving Average 44.13
50-Day Moving Average 38.33
20-Day Moving Average 36.62
10-Day Moving Average 36.35
Average True Range 1.89
ADX 14.89
+DI 18.08
-DI 21.94
Chandelier Exit (Long, 3 ATRs ) 34.82
Chandelier Exit (Short, 3 ATRs ) 39.25
Upper Bollinger Band 38.76
Lower Bollinger Band 34.48
Percent B (%b) 0.52
BandWidth 11.69
MACD Line -0.52
MACD Signal Line -0.71
MACD Histogram 0.1839
Fundamentals Value
Market Cap 1.63 Billion
Num Shares 44.5 Million
EPS -2.80
Price-to-Earnings (P/E) Ratio -13.13
Price-to-Sales 368.82
Price-to-Book 9.86
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.58
Resistance 3 (R3) 39.44 38.34 39.10
Resistance 2 (R2) 38.34 37.61 38.41 38.94
Resistance 1 (R1) 37.52 37.15 36.97 37.66 38.78
Pivot Point 36.42 36.42 36.15 36.49 36.42
Support 1 (S1) 35.60 35.69 35.05 35.74 34.62
Support 2 (S2) 34.50 35.23 34.57 34.46
Support 3 (S3) 33.68 34.50 34.30
Support 4 (S4) 33.82